Laurion Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-100,000
Closed -$78M 356
2025
Q2
$78M Buy
+100,000
New +$77.7M 1.41% 20
2025
Q1
Sell
-10,800
Closed -$8.34M 338
2024
Q4
$8.34M Buy
+10,800
New +$8.94M 0.15% 107
2021
Q4
Sell
-9,300
Closed -$2.15M 655
2021
Q3
$2.15M Buy
+9,300
New +$2.3M 0.01% 431
2020
Q2
Sell
-3,500
Closed -$486K 1047
2020
Q1
$486K Buy
+3,500
New +$481K 0.01% 587
2019
Q4
Sell
-350,000
Closed -$39.1M 1074
2019
Q3
$39.1M Buy
+350,000
New +$39M 0.29% 80
2018
Q4
Sell
-260,600
Closed -$28M 1274
2018
Q3
$28M Buy
260,600
+220,600
+552% +$22.1M 0.27% 62
2018
Q2
$3.41M Hold
40,000
0.03% 450
2018
Q1
$3.1M Hold
40,000
0.02% 501
2017
Q4
$3.38M Hold
40,000
0.02% 636
2017
Q3
$3.42M Sell
40,000
-20,500
-34% -$1.68M 0.02% 609
2017
Q2
$4.98M Sell
60,500
-557,600
-90% -$45.5M 0.03% 502
2017
Q1
$52M Buy
618,100
+578,100
+1,445% +$46.3M 0.39% 57
2016
Q4
$2.94M Buy
+40,000
New +$2.98M 0.03% 477

Other funds holding LLY

Laurion Capital Management's LLY Position: Q4 2024 in Review

Laurion Capital Management sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 3,328 shares — an estimated $2.76M sold.

Laurion Capital Management first reported a position in LLY in Q1 2016 and held it in 11 quarters. The position peaked at $28.6M in Q3 2021. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Laurion Capital Management reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • Laurion Capital Management sold 3,328 Eli Lilly shares in Q4 2024, an estimated $2.76M.
  • Laurion Capital Management first reported a position in Eli Lilly in Q1 2016 and held it in 11 quarters.
  • Laurion Capital Management's Eli Lilly position peaked at $28.6M in Q3 2021.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Laurion Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.